APPI - UT'ing on NEWS - .0028 .0029
Advanced Plant Pharmaceuticals, Inc. Announces Plans to Acquire Biodiesel Producer World Health Energy, Inc.
(PrimeZone 11/09 05:30:18)
>NEW YORK, Nov. 9, 2006 (PRIMEZONE) -- Advanced Plant Pharmaceuticals Inc.
(OTCBB:APPI) today announces signing a Memorandum of Understanding ("MOU") to
acquire the Biodiesel company, World Health Energy, Inc. World Health Energy,
Inc. ("WHE") is an emerging energy company focusing on biofuels and renewable
energy production and distribution.
Biodiesel refers to a diesel-equivalent, processed fuel derived from biological
sources. Though derived from biological sources, it is a processed fuel that can
be readily used in diesel-engined vehicles, which distinguishes biodiesel from
the straight vegetable oils or waste vegetable oils used as fuels in some
modified diesel vehicles. Biodiesel is biodegradable and non-toxic, and has
significantly fewer emissions than petroleum-based diesel when burned. Biodiesel
functions in current diesel engines, and could in theory supplement fossil fuels
as the world's primary transport energy source. Biodiesel reduces emissions of
carbon monoxide (CO) by approximately 50% and carbon dioxide by 78% on a net
lifecycle basis.
Biodiesel can also be used as a heating fuel in domestic and commercial boilers.
Biodiesel can be distributed using today's infrastructure, and its use and
production are increasing rapidly. Fuel stations are beginning to make biodiesel
available to consumers, and a growing number of transport fleets use it as an
additive in their fuel.
World Health Energy, Inc. plans to use renewable, cost-effective agricultural
products from around the world to develop natural alternative fuels and
marketable agricultural by-products such as feedstock. WHE's proposed Biodiesel
production plant is designed to produce biodiesel that complies to or exceeds
international biodiesel production requirements and standards, including the
European standard for Biodiesel EN 14214 as well as ASTM D6751 specifications.
In addition to renewable energy production, WHE's unique process will create a
newly engineered feedstock as a by-product of the biodiesel production. Due to a
feedstock shortages worldwide, the company plans to sell the feedstock as a
secondary source of revenue, capitalizing on all aspects of the biodiesel
production process.
Under the terms of the MOU, Advanced Plant Pharmaceuticals, Inc. would acquire
World Health Energy, Inc. in return for 20% of APPI. Additionally, APPI would
change the name of the company to World Health Energy, Inc. and a new ticker
symbol will be applied for in the near future.
David Harel, President of WHE said, "Bio Diesel is a multi-billiondollar
industry and World Health Energy is well positioned forthis exciting market.
APPI's experience in the development of Whole PlantPharmaceuticals has the
potential of identifying opportunities of creatingfeed stock with higher yields
resulting in higher profit margins. We arelooking forward to completing the MOU
process to add WHE to our company andlaunch our operations into the renewable
energy industry."
To be added to APPI's corporate e-mail list for shareholders and interested
investors, please send an e-mail to ir@advancedplantpharm.com.
About World Health Energy Inc. (www.worldhealthenergy.com)
World Health Energy, Inc. is an emerging renewable energy and biofuel company.
The company will produce and market high-quality, low cost B100 Biodiesel to
replace traditional fossil fuels.
About Advanced Plant Pharmaceuticals, Inc. (www.advancedplantpharm.com)
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and
development of whole plant-based nutritionals. The company has a
composition-oriented patent for a proprietary process of utilizing whole plants
to safely manufacture all-natural nutritional supplements. APPI markets and
distributes its line of products including Lo-Chol(tm) worldwide through various
sales distribution channels.
"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF
1995
This press release contains forward-looking statements that involve risks and
uncertainties. The statements in this release are forward-looking statements
that are made pursuant to safe harbor provision of the Private Securities
Litigation Reform Act of 1995. Actual results, events and performance could vary
materially from those contemplated by these forward-looking statements. These
statements involve known and unknown risks and uncertainties, which may cause
Advanced Plant Pharmaceuticals, Inc actual results in future periods to differ
materially from results expressed or implied by forward-looking statements.
These risks and uncertainties include, among other things, product demand and
market competition. You should independently investigate and fully understand
all risks before making investment decisions.
CONTACT: For Advanced Plant Pharmaceuticals Inc.:
LC Group
Investor Relations
Rick Lutz
(404) 261-1196
ir@advancedplantpharm.com
www.advancedplantpharm.com
S.PZ APPI MERGE.PZ PROD.PZ
